Abstract Background/Aim: Hyaluronic acid (HA) is a large glycosaminoglycan composed of
an extracellular matrix. The HA-rich microenvironment and receptors of HA have been …

Objectives To evaluate hyaluronan‐mediated motility receptor (RHAMM) expression in
normal, hyperplasic and neoplastic prostate tissue after various types and durations of …

Receptor for hyaluronic acid (HA)‑mediated motility (RHAMM) expression is upregulated in
pancreatic ductal adenocarcinoma (PDAC). In the present study, small interfering RNA …

Receptor for hyaluronic acid (HA)-mediated motility (RHAMM) is a nonintegral cell surface
receptor involved in the aggressive phenotype in a wide spectrum of human malignancies …

Hepatocellular carcinoma (HCC) is one of the most common types of cancer across the
world. Hyaluronic acid (HA) has been reported to serve an important role in tumor extension …

The receptor for hyaluronic acid-mediated motility (RHAMM) is upregulated in various
cancers, but its role in primary and metastatic non-small cell lung carcinoma (NSCLC) …

Abstract Expression of Receptor for Hyaluronic Acid Mediated Motility (RHAMM) increases
cellular motility and RHAMM overexpression promotes invasive phenotype and metastasis …

The receptor for hyaluronic acid-mediated motility (RHAMM) is upregulated in various
cancers. We previously screened genes upregulated in human hepatocellular carcinomas …

Background Elevated hyaluronan-mediated motility receptor (RHAMM) has been reported to
contribute to disease progression, aggressive phenotype and poor prognosis in multiple …

In colorectal cancer (CRC), RHAMM is an independent adverse prognostic factor. The aim of
the study was therefore to investigate on the role of RHAMM as a potential direct driver of …